Sandbox:risk: Difference between revisions

Revision as of 01:22, 10 October 2015

Patients with stage 1 tumor irrespective of the age, grade, and molecular pathway
Patients with stage 2A/2B (>50% resected), irrespective of age, irrespective of the grade, MYCN not amplified
Patients with Stage 4S, <365 days of age, favorable histology, DNA index >1 , MYCN not amplified

Low risk neuroblastoma patients

@@ Line 7: / Line 7: @@
 *'''Irrespective of molecular pathway'''</div>}}
 {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }}
-{{familytree | | | | | | C01 |-|+|-| B01 | | | | |C01=Low risk neuroblastoma patients  |B01= }}
+{{familytree | | | | | | C01 |-|+|-| B01 | | | | |C01=<div style="width: 20em; padding:0em;text-align:center">'''Low risk neuroblastoma patients'''</div>|B01=<div style="width: 20em; padding:0em;text-align:left">
+*'''INSS stage 2A/2B (>50% resected)'''<br>
+*'''Irrespective of age'''<br>
+*'''Irrespective of grade'''<br>
+*'''''MYCN'' not amplified'''</div>}}
 {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | }}
-{{familytree | | | | | | | | | |`|-| C02 | | | | | | |C02= }}
+{{familytree | | | | | | | | | |`|-| C02 | | | | | | |C02=<div style="width: 20em; padding:0em;text-align:left">
+*'''INNS stage 4S'''<br>
+*'''<365 days of age'''<br>
+*'''Favorable histology'''<br>
+*'''DNA index >1'''<br>
+*'''''MYCN'' not amplified'''</div>}}
 * '''Low risk neuroblastoma patients''' include:
 :* Patients with stage 1 tumor irrespective of the age, grade, and molecular pathway
-:* Patients with stage 2A/2B (>50% resected), irrespective of age, irrespective of the grade, ''MYCN''not amplified
+:* Patients with stage 2A/2B (>50% resected), irrespective of age, irrespective of the grade, ''MYCN'' not amplified
 :* Patients with Stage 4S, <365 days of age, favorable histology, DNA index >1 , ''MYCN'' not amplified